Back to results
CompletedPhase 1Phase 2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease

NCT03257046

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Atlanta Center for Medical Research

Atlanta, Georgia, United States

+1 additional location

View on ClinicalTrials.gov
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease — TrialFind